Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
ELVN
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
ELVN: Enliven Therapeutics, Inc. Stock Analysis | finqOS
ELVN
$46.53
+0.26%
Lists
Call ELVN
Enliven Therapeutics
ELVN
Back
Lists
Call ELVN
$46.53
+$0.12 · +0.26%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
22%
in three months and
67%
of the way up its 52-week range.
Call ELVN
Loading chart data...
Signal state